Stem cell therapy offers hope for butterfly children with fragile skin
NCT ID NCT05838092
First seen Dec 17, 2025 · Last updated May 25, 2026 · Updated 21 times
Summary
This study tests a treatment made from special stem cells (ABCB5+ MSCs) given through an IV to people with epidermolysis bullosa, a rare disease that causes fragile, blistering skin. The main goal is to see if it safely helps close chronic wounds. The trial includes children as young as 6 months and adults with a confirmed diagnosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPIDERMOLYSIS BULLOSA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
-
Masonic Cancer Center and Medical Center Minneapolis
Minneapolis, Minnesota, 55455, United States
Conditions
Explore the condition pages connected to this study.